Since then, more than ten types of GLP-1 receptor agonists have received FDA approval and been brought to market, and with each new version, their effectiveness has increased
If cardiovascular health is what you think is important for deciding between these drug classes, I think our most recent study provides some strong evidence
The study looked back on their health records for up to three years, beginning when they started taking either a GLP-1 receptor agonist most commonly semaglutide, liraglutide or dulaglutide or another type of medication, called an SGLT2 inhibitor, to treat their diabetes
GLP-1 injections may not be suitable for everyone
Frontiers in Microbiology, 12 , 639948
MAUD-T2D trial (n = 3,178): Alcohol-related hospitalization occurred in 12.9% of newer GLP-1 RA users and 31.1% of MAUD users